SE504902C2 - Beredning för påvisande av Helicobacter pylori i magsäcken - Google Patents
Beredning för påvisande av Helicobacter pylori i magsäckenInfo
- Publication number
- SE504902C2 SE504902C2 SE9403755A SE9403755A SE504902C2 SE 504902 C2 SE504902 C2 SE 504902C2 SE 9403755 A SE9403755 A SE 9403755A SE 9403755 A SE9403755 A SE 9403755A SE 504902 C2 SE504902 C2 SE 504902C2
- Authority
- SE
- Sweden
- Prior art keywords
- stomach
- urea
- acid
- preparation
- isotope
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 210000002784 stomach Anatomy 0.000 title claims abstract description 23
- 241000590002 Helicobacter pylori Species 0.000 title claims abstract description 12
- 229940037467 helicobacter pylori Drugs 0.000 title claims abstract description 11
- 238000001514 detection method Methods 0.000 title 1
- 239000004202 carbamide Substances 0.000 claims abstract description 40
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims abstract description 39
- 239000002253 acid Substances 0.000 claims abstract description 14
- 239000007787 solid Substances 0.000 claims abstract description 14
- 108010046334 Urease Proteins 0.000 claims abstract description 10
- 230000000694 effects Effects 0.000 claims abstract description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 238000009472 formulation Methods 0.000 claims description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- 238000004090 dissolution Methods 0.000 claims description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- 235000010323 ascorbic acid Nutrition 0.000 claims description 2
- 239000011668 ascorbic acid Substances 0.000 claims description 2
- 235000015165 citric acid Nutrition 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 239000011975 tartaric acid Substances 0.000 claims description 2
- 235000002906 tartaric acid Nutrition 0.000 claims description 2
- 150000007513 acids Chemical class 0.000 claims 1
- 239000007795 chemical reaction product Substances 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 210000000214 mouth Anatomy 0.000 abstract description 4
- 241000589989 Helicobacter Species 0.000 abstract 1
- 206010019375 Helicobacter infections Diseases 0.000 abstract 1
- 210000003800 pharynx Anatomy 0.000 abstract 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 16
- 239000007864 aqueous solution Substances 0.000 description 12
- 239000001569 carbon dioxide Substances 0.000 description 8
- 229910002092 carbon dioxide Inorganic materials 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000013543 active substance Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000009858 acid secretion Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 239000007903 gelatin capsule Substances 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 239000008279 sol Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 229940069428 antacid Drugs 0.000 description 2
- 239000003159 antacid agent Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002360 explosive Substances 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000000449 pharmaceutical disintegrant Substances 0.000 description 2
- 230000000405 serological effect Effects 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000167880 Hirundinidae Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229960004543 anhydrous citric acid Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000002575 gastroscopy Methods 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- -1 hydrogen ions Chemical class 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 239000007962 solid dispersion Substances 0.000 description 1
- 239000006104 solid solution Substances 0.000 description 1
- 238000005563 spheronization Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1206—Administration of radioactive gases, aerosols or breath tests
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
- A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Atmospheric Sciences (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9403755A SE504902C2 (sv) | 1994-11-02 | 1994-11-02 | Beredning för påvisande av Helicobacter pylori i magsäcken |
| DE69533362.3T DE69533362T3 (de) | 1994-11-02 | 1995-10-17 | Diagnostisches Präparat zum Aufspüren von Helicobacter Pylori |
| ES95936815.0T ES2227560T5 (es) | 1994-11-02 | 1995-10-17 | Preparación diagnóstica para la detección de Helicobacter pilori |
| US08/836,282 US6113875A (en) | 1994-11-02 | 1995-10-17 | Diagnostic preparation for detection of helicobacter pylori |
| PCT/SE1995/001212 WO1996014091A1 (en) | 1994-11-02 | 1995-10-17 | Diagnostic preparation for detection of helicobacter pylori |
| EP95936815.0A EP0787017B2 (de) | 1994-11-02 | 1995-10-17 | Diagnostisches präparat zum aufspüren von helicobacter pylori |
| NZ295275A NZ295275A (en) | 1994-11-02 | 1995-10-17 | Diagnostic preparation for detection of helicobacter pylori |
| AU38610/95A AU696375B2 (en) | 1994-11-02 | 1995-10-17 | Diagnostic preparation for detection of helicobacter pylori |
| AT95936815T ATE273028T1 (de) | 1994-11-02 | 1995-10-17 | Diagnostisches präparat zum aufspüren von helicobacter pylori |
| PT95936815T PT787017E (pt) | 1994-11-02 | 1995-10-17 | Preparacao de diagn¾stico para deteccao de helicobacter pylori |
| JP8515232A JP2768559B2 (ja) | 1994-11-02 | 1995-10-17 | ヘリコバクテル・ピロリ（Ｈｅｌｉｃｏｂａｃｔｅｒ Ｐｙｌｏｒｉ）の検出のための診断用調剤 |
| CA002203014A CA2203014C (en) | 1994-11-02 | 1995-10-17 | Diagnostic preparation for detection of heliobacter pylori |
| DK95936815.0T DK0787017T4 (da) | 1994-11-02 | 1995-10-17 | Diagnostisk præparat til påvisning af helicobacterpylori |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9403755A SE504902C2 (sv) | 1994-11-02 | 1994-11-02 | Beredning för påvisande av Helicobacter pylori i magsäcken |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE9403755D0 SE9403755D0 (sv) | 1994-11-02 |
| SE9403755L SE9403755L (sv) | 1996-05-03 |
| SE504902C2 true SE504902C2 (sv) | 1997-05-26 |
Family
ID=20395828
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9403755A SE504902C2 (sv) | 1994-11-02 | 1994-11-02 | Beredning för påvisande av Helicobacter pylori i magsäcken |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6113875A (de) |
| EP (1) | EP0787017B2 (de) |
| AT (1) | ATE273028T1 (de) |
| AU (1) | AU696375B2 (de) |
| CA (1) | CA2203014C (de) |
| DE (1) | DE69533362T3 (de) |
| ES (1) | ES2227560T5 (de) |
| NZ (1) | NZ295275A (de) |
| PT (1) | PT787017E (de) |
| SE (1) | SE504902C2 (de) |
| WO (1) | WO1996014091A1 (de) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9601659D0 (sv) * | 1996-04-30 | 1996-04-30 | Diabact Ab | Diagnostisk läkemedelsberedning |
| EP0860170B1 (de) * | 1996-08-13 | 2000-03-22 | Kyowa Hakko Kogyo Co., Ltd. | Tabletten auf basis von isotopenmarkiertem harnstoff |
| ES2120903B1 (es) * | 1996-11-12 | 1999-05-16 | Isomed S L | Metodo y kit para la deteccion de helicobacter pylori. |
| MX9703918A (es) * | 1997-05-28 | 1998-11-30 | J Marshall M D Barry | Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior. |
| US6284219B1 (en) | 1998-06-30 | 2001-09-04 | Phenome Sciences Inc. | In vivo determination of metabolic function for use in therapy management |
| US6656127B1 (en) | 1999-06-08 | 2003-12-02 | Oridion Breathid Ltd. | Breath test apparatus and methods |
| AU5243100A (en) | 1999-06-08 | 2000-12-28 | Oridion Medical (1987) Ltd. | Gas analyzer calibration checking device |
| WO2001082979A1 (en) * | 2000-05-02 | 2001-11-08 | Otsuka Pharmaceutical Co., Ltd. | Preparations for evaluating eliminative ability of stomach |
| US7201891B1 (en) * | 2000-05-19 | 2007-04-10 | Otsuka Pharmaceutical Co., Ltd. | Pharmaceutical preparation for the diagnosis of helicobacter pylori infection |
| KR100774014B1 (ko) * | 2000-05-19 | 2007-11-08 | 오츠카 세이야쿠 가부시키가이샤 | 헬리코박터 파이로리 감염의 진단용 제제 |
| AU7458501A (en) * | 2000-06-21 | 2002-01-02 | Otsuka Pharma Co Ltd | Preparations for measruing gastric ph value and method of measuring gastric ph value by using the same |
| MXPA04001246A (es) * | 2001-08-09 | 2005-06-06 | Aygen Sitke | Metodo para diagnostico de infeccion por helicobacter pylori y kit de diagnostico para efectuar el mismo. |
| US7033838B2 (en) * | 2001-08-09 | 2006-04-25 | Sitke Aygen | Method for the diagnosis of Helicobacter pylori infection, and a diagnostic kit for performing the method |
| USD485359S1 (en) | 2001-10-15 | 2004-01-13 | Kimberly-Clark Worldwide, Inc. | Specimen-handling tool |
| US6929926B2 (en) | 2001-10-15 | 2005-08-16 | Barry J. Marshall | Composition for the detection of gastrointestinal disorders |
| US20030073155A1 (en) * | 2001-10-15 | 2003-04-17 | Mcmichael Donald J. | Methods for performing multiple diagnostic tests |
| US20030072686A1 (en) * | 2001-10-15 | 2003-04-17 | Marshall Barry J. | Systems for performing multiple diagnostic tests |
| USD467348S1 (en) | 2001-10-15 | 2002-12-17 | Kimberly-Clark Worldwide, Inc. | Diagnostic test carrier |
| US6998250B2 (en) | 2001-10-15 | 2006-02-14 | Donald J. McMichael | Method for detecting Helicobacter pylori |
| US7008777B2 (en) * | 2001-10-15 | 2006-03-07 | Barry J. Marshall | System for the detection of urease and method for using same |
| USD470241S1 (en) | 2001-12-17 | 2003-02-11 | Kimberly-Clark Worldwide, Inc. | Specimen-handling tool |
| USD470597S1 (en) | 2001-12-17 | 2003-02-18 | Kimberly-Clark Worldwide, Inc. | Diagnostic test kit |
| USD469881S1 (en) | 2001-12-17 | 2003-02-04 | Kimberly-Clark Worldwide, Inc. | Two-well diagnostic test kit with specimen-handling tool |
| USD484988S1 (en) | 2001-12-17 | 2004-01-06 | Kimberly-Clark Worldwide, Inc. | Diagnostic test kit with specimen-handling tool |
| USD471639S1 (en) | 2001-12-17 | 2003-03-11 | Kimberly-Clark Worldwide, Inc. | Tool for handling a specimen |
| USD470596S1 (en) | 2001-12-17 | 2003-02-18 | Kimberly-Clark Worldwide, Inc. | Test kit specimen-handling tool |
| US6783976B2 (en) | 2001-12-21 | 2004-08-31 | Kimberly-Clark Worldwide, Inc. | Carrier and specimen-handling tool for use in diagnostic testing |
| KR100477364B1 (ko) * | 2002-07-03 | 2005-03-22 | 주식회사 메디켐스 | 신규한 헬리코박터 파이로리 균 진단용 13ｃ-요소 캅셀 제제 |
| RU2214819C1 (ru) * | 2002-09-03 | 2003-10-27 | Открытое акционерное общество "Щелковский витаминный завод" | Упаковка лекарственных средств для лечения или предотвращения желудочно-кишечных заболеваний, вызываемых или опосредуемых заражением helicobacter pylori |
| EP1685850A1 (de) * | 2005-02-01 | 2006-08-02 | Sitke Dr. Aygen | Verfahren zur Bestimmung von Helicobacter Pylori und Bestimmungskit zur Durchführung des Verfahrens |
| CA2616788C (en) * | 2005-07-25 | 2014-01-07 | Otsuka Pharmaceutical Co., Ltd. | Oral preparation useful in measuring capacity to metabolize pyridine |
| TWI409091B (zh) * | 2006-04-13 | 2013-09-21 | Otsuka Pharma Co Ltd | Digestive tube syndrome diagnosis and treatment |
| WO2014030650A1 (ja) | 2012-08-20 | 2014-02-27 | 大塚製薬株式会社 | 糖代謝能の測定方法及びそれに使用する組成物 |
| DE102012017854A1 (de) | 2012-09-08 | 2014-05-28 | Kronos International, Inc. | Infrarot-reflektierendes Pigment auf Basis Titandioxid sowie Verfahren zu seiner Herstellung |
| ES2754246T3 (es) | 2013-03-15 | 2020-04-16 | Otsuka Pharma Co Ltd | Composición para su uso en un método para medir la razón de combustión azúcar/ácido graso |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE294634C (de) * | ||||
| JPS61191610A (ja) * | 1985-02-20 | 1986-08-26 | Dai Ichi Kogyo Seiyaku Co Ltd | 胃液中で速やかに溶解する錠剤 |
| DK161428C (da) * | 1985-05-10 | 1991-12-16 | Fertin Lab As | Fast, oralt cariesmodvirkende middel |
| WO1987005804A1 (en) * | 1986-04-01 | 1987-10-08 | The Upjohn Company | Methylprednisolone/sodium carboxymethyl starch tablet composition |
| US4830010A (en) * | 1986-04-04 | 1989-05-16 | Marshall Barry J | Methods for the diagnosis of gastrointestinal disorders |
| US4923801A (en) * | 1987-04-13 | 1990-05-08 | The University Of Virginia Alumni Patents Foundation | Compositions and methods for the enrichment and isolation of Campylobacter pylori and related organisms from biological specimens and the environment |
| DE68916983T2 (de) * | 1988-02-25 | 1995-01-19 | Yamanouchi Europ Bv | Verfahren zur Herstellung eines pharmazeutischen Granulats. |
| US5064650A (en) * | 1988-04-19 | 1991-11-12 | Southwest Research Institute | Controlled-release salt sensitive capsule for oral use and adhesive system |
| DD294634A5 (de) * | 1990-05-21 | 1991-10-10 | Zi Fuer Isotopen- Und Strahlenforschung,De | Mittel zur nichtinvasiven diagnose der helicobacter-pylori-gastritis |
| JP2609022B2 (ja) * | 1990-11-29 | 1997-05-14 | 北陸製薬株式会社 | ポリカルボフィルカルシウム含有製剤 |
| CN1137732C (zh) * | 1993-10-28 | 2004-02-11 | 巴瑞·马休 | 胃内幽门螺杆菌的检测 |
| US5542419A (en) * | 1994-02-28 | 1996-08-06 | Boston University | Noninvasive method to detect gastric Helicobacter pylori |
-
1994
- 1994-11-02 SE SE9403755A patent/SE504902C2/sv not_active IP Right Cessation
-
1995
- 1995-10-17 NZ NZ295275A patent/NZ295275A/en not_active IP Right Cessation
- 1995-10-17 DE DE69533362.3T patent/DE69533362T3/de not_active Expired - Lifetime
- 1995-10-17 ES ES95936815.0T patent/ES2227560T5/es not_active Expired - Lifetime
- 1995-10-17 PT PT95936815T patent/PT787017E/pt unknown
- 1995-10-17 AT AT95936815T patent/ATE273028T1/de active
- 1995-10-17 US US08/836,282 patent/US6113875A/en not_active Expired - Lifetime
- 1995-10-17 WO PCT/SE1995/001212 patent/WO1996014091A1/en not_active Ceased
- 1995-10-17 CA CA002203014A patent/CA2203014C/en not_active Expired - Fee Related
- 1995-10-17 AU AU38610/95A patent/AU696375B2/en not_active Ceased
- 1995-10-17 EP EP95936815.0A patent/EP0787017B2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0787017A1 (de) | 1997-08-06 |
| DE69533362T2 (de) | 2005-07-28 |
| AU696375B2 (en) | 1998-09-10 |
| ES2227560T5 (es) | 2014-03-10 |
| SE9403755D0 (sv) | 1994-11-02 |
| CA2203014C (en) | 2003-05-13 |
| DE69533362D1 (de) | 2004-09-16 |
| AU696375C (en) | 1996-05-31 |
| EP0787017B1 (de) | 2004-08-11 |
| NZ295275A (en) | 1998-08-26 |
| EP0787017B2 (de) | 2014-01-01 |
| DE69533362T3 (de) | 2014-03-13 |
| ES2227560T3 (es) | 2005-04-01 |
| AU3861095A (en) | 1996-05-31 |
| SE9403755L (sv) | 1996-05-03 |
| US6113875A (en) | 2000-09-05 |
| CA2203014A1 (en) | 1996-05-17 |
| WO1996014091A1 (en) | 1996-05-17 |
| ATE273028T1 (de) | 2004-08-15 |
| PT787017E (pt) | 2004-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE504902C2 (sv) | Beredning för påvisande av Helicobacter pylori i magsäcken | |
| CN1137732C (zh) | 胃内幽门螺杆菌的检测 | |
| Digenis et al. | Gastrointestinal behavior of orally administered radiolabeled erythromycin pellets in man as determined by gamma scintigraphy | |
| EP0896547B1 (de) | Diagnostische zusammensetzung | |
| KR100774014B1 (ko) | 헬리코박터 파이로리 감염의 진단용 제제 | |
| US6517809B1 (en) | Process for preparing a reactive pharmaceutical product for the detection of gastrointestinal disorder caused by bacteria in the gastrointestinal superior tract | |
| JPH10500995A (ja) | ヘリコバクテル・ピロリ（Ｈｅｌｉｃｏｂａｃｔｅｒ Ｐｙｌｏｒｉ）の検出のための診断用調剤 | |
| US7201891B1 (en) | Pharmaceutical preparation for the diagnosis of helicobacter pylori infection | |
| US4661338A (en) | Process for determining hypoacidity | |
| Yassin et al. | Intra-gastric performance and bioavailability study of a new per-oral bioadhesive verapamil HC1 matrix tablet in dogs | |
| HK1029063A (en) | Process for preparing a reative pharmaceutical product for the detection of gastrointestinal disorder caused by bacteria in the gastrointestinal superior tract |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |